Darlene Jones
Corneal and Contact Management · Plano, TXNPI 1528088291
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,145 of the $9,156 with a category attached, or 89.0%. It is spread thinly across 21 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Among corneal and contact management clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $95.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$2K
- Johnson & Johnson Vision Care, Inc.$2K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Alcon$766
- Bausch & Lomb Americas Inc.$666
- LKC Technologies, Inc.$372
- plus $2K from 15 others
What the payments were for
- Travel & lodging$89910%
- Food & beverage$8,14589%
- Gifts$190%
- Entertainment$931%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 2 | $2,182 |
| Johnson & Johnson Vision Care, Inc. | 37 | $1,776 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $1,117 |
| Alcon | 16 | $766 |
| Bausch & Lomb Americas Inc. | 6 | $666 |
| LKC Technologies, Inc. | 4 | $372 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $348 |
| Oculus, Inc. | 1 | $235 |
| AbbVie(2 entities) | 3 | $229 |
| Sun Pharmaceutical Industries Inc. | 3 | $223 |
| Eyevance Pharmaceuticals LLC | 2 | $220 |
| Coopervision Inc. | 2 | $175 |
| Glaukos Corporation | 1 | $168 |
| Novartis | 1 | $123 |
| Dompe US, Inc. | 1 | $115 |
| Kala Pharmaceuticals, Inc. | 1 | $111 |
| Biotissue Holdings Inc. | 1 | $108 |
| Optos, Inc. | 1 | $93 |
| Oyster Point Pharma, Inc. | 1 | $80 |
| Avedro Inc. | 1 | $30 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,156 in reported general payments places this provider in the 90th percentile of 103 corneal and contact management providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other corneal and contact management in Plano
- Danny MalonePlano$7K
- James WilliamsPlano$6K
- Hyejon KoPlano$3K
- Deborah MoonPlano$942
- Maurice WilsonConroe$362K
- Roberto SaenzSan Antonio$171K
- Fariba ParmerGrapevine$26K
- Vissett SunHouston$13K
- Napoleon LoveroHouston$12K
- Sairah MalikHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.